Sort by
Items per page

Send to

Choose Destination

Best matches for type 2 diabetes hepatitis C:

Hepatitis C virus infection and type 2 diabetes. Fallahi P et al. Clin Ter. (2013)

[Correction of dyslipidemia in patients with chronic hepatitis C, combined with diabetes type 2]. Derbak M et al. Georgian Med News. (2014)

Virus C hepatitis and type 2 diabetes: a cohort study in southern Italy. Montenegro L et al. Am J Gastroenterol. (2013)

Search results

Items: 1 to 20 of 607


Hepatocellular carcinoma as a leading cause of cancer-related deaths in Japanese type 2 diabetes mellitus patients.

Shima T, Uto H, Ueki K, Kohgo Y, Yasui K, Nakamura N, Nakatou T, Takamura T, Kawata S, Notsumata K, Sakai K, Tateishi R, Okanoue T.

J Gastroenterol. 2018 Jul 13. doi: 10.1007/s00535-018-1494-7. [Epub ahead of print]


Streptococcus pyogenes and invasive central nervous system infection.

Randhawa E, Woytanowski J, Sibliss K, Sheffer I.

SAGE Open Med Case Rep. 2018 May 31;6:2050313X18775584. doi: 10.1177/2050313X18775584. eCollection 2018.


Modeling NAFLD Disease Burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030.

Estes C, Anstee QM, Teresa Arias-Loste M, Bantel H, Bellentani S, Caballeria J, Colombo M, Craxi A, Crespo J, Day CP, Eguchi Y, Geier A, Kondili LA, Kroy DC, Lazarus JV, Loomba R, Manns MP, Marchesini G, Nakajima A, Negro F, Petta S, Ratziu V, Romero-Gomez M, Sanyal A, Schattenberg JM, Tacke F, Tanaka J, Trautwein C, Wei L, Zeuzem S, Razavi H; NAFLD / NASH Working Group.

J Hepatol. 2018 Jun 8. pii: S0168-8278(18)32121-4. doi: 10.1016/j.jhep.2018.05.036. [Epub ahead of print]


Prevalence and predictive factors of moderate/severe liver steatosis in chronic hepatitis C (CHC) infected patients evaluated with controlled attenuation parameter (CAP).

Cardoso AC, Perez RM, de Figueiredo-Mendes C, Carvalho Leite N, Moraes-Coelho HS, Villela-Nogueira CA.

J Viral Hepat. 2018 May 16. doi: 10.1111/jvh.12930. [Epub ahead of print]


Hepatitis C Virus NS5A Protein Promotes the Lysosomal Degradation of Hepatocyte Nuclear Factor 1α via Chaperone-Mediated Autophagy.

Matsui C, Deng L, Minami N, Abe T, Koike K, Shoji I.

J Virol. 2018 Jun 13;92(13). pii: e00639-18. doi: 10.1128/JVI.00639-18. Print 2018 Jul 1.


A systematic review of interventions by healthcare professionals to improve management of non-communicable diseases and communicable diseases requiring long-term care in adults who are homeless.

Hanlon P, Yeoman L, Gibson L, Esiovwa R, Williamson AE, Mair FS, Lowrie R.

BMJ Open. 2018 Apr 7;8(4):e020161. doi: 10.1136/bmjopen-2017-020161.


Prevalence and genotype distribution of hepatitis C virus infection among patients with type 2 diabetes mellitus.

Farshadpour F, Taherkhani R, Ravanbod MR, Eghbali SS.

Med Princ Pract. 2018 Apr 5. doi: 10.1159/000488985. [Epub ahead of print]


Impact of sustained virologic response on risk of type 2 diabetes among hepatitis C patients in the United States.

Li J, Zhang T, Gordon SC, Rupp LB, Trudeau S, Holmberg SD, Moorman AC, Spradling PR, Teshale EH, Boscarino JA, Schmidt MA, Daida YG, Lu M; CHeCS Investigators.

J Viral Hepat. 2018 Feb 25. doi: 10.1111/jvh.12887. [Epub ahead of print]


Metformin Use Reverses the Increased Mortality Associated With Diabetes Mellitus During Tuberculosis Treatment.

Degner NR, Wang JY, Golub JE, Karakousis PC.

Clin Infect Dis. 2018 Jan 6;66(2):198-205. doi: 10.1093/cid/cix819.


Hepatitis C virus infection and development of type 2 diabetes mellitus: Systematic review and meta-analysis of the literature.

Fabiani S, Fallahi P, Ferrari SM, Miccoli M, Antonelli A.

Rev Endocr Metab Disord. 2018 Jan 11. doi: 10.1007/s11154-017-9440-1. [Epub ahead of print] Review.


Mechanism of Hepatitis C Virus-Induced Diabetes Mellitus.

Ashfaq UA, Khalid H.

Crit Rev Eukaryot Gene Expr. 2017;27(4):363-371. doi: 10.1615/CritRevEukaryotGeneExpr.2017020437.


Interaction and joint effect of ALT and chronic liver disease on liver cancer in type 2 diabetes patients.

Li TC, Li CI, Liu CS, Lin PH, Lin WY, Lin CH, Yang SY, Chiang JH, Lin CC.

Oncotarget. 2017 Oct 10;8(61):103851-103863. doi: 10.18632/oncotarget.21804. eCollection 2017 Nov 28.


A preliminary analysis of hepatitis C virus in pancreatic islet cells.

Blackard JT, Kong L, Lombardi A, Homann D, Hammerstad SS, Tomer Y.

Virol J. 2017 Dec 20;14(1):237. doi: 10.1186/s12985-017-0905-3.


Hepatitis C virus clearance by direct-acting antiviral treatments and impact on insulin resistance in chronic hepatitis C patients.

Adinolfi LE, Nevola R, Guerrera B, D'Alterio G, Marrone A, Giordano M, Rinaldi L.

J Gastroenterol Hepatol. 2018 Jul;33(7):1379-1382. doi: 10.1111/jgh.14067. Epub 2018 Feb 27.


Hepcidin in Iron Homeostasis: Diagnostic and Therapeutic Implications in Type 2 Diabetes Mellitus Patients.

Ambachew S, Biadgo B.

Acta Haematol. 2017;138(4):183-193. doi: 10.1159/000481391. Epub 2017 Nov 15. Review.


Hepatitis C Virus-Associated Cancers.

Yi Z, Yuan Z.

Adv Exp Med Biol. 2017;1018:129-146. doi: 10.1007/978-981-10-5765-6_8. Review.


Significant improvement of glycemic control in diabetic patients with HCV infection responding to direct-acting antiviral agents.

Ciancio A, Bosio R, Bo S, Pellegrini M, Sacco M, Vogliotti E, Fassio G, Bianco Mauthe Degerfeld AGF, Gallo M, Giordanino C, Terzi di Bergamo L, Ribaldone D, Bugianesi E, Smedile A, Rizzetto M, Saracco GM.

J Med Virol. 2018 Feb;90(2):320-327. doi: 10.1002/jmv.24954. Epub 2017 Nov 14.


Influence of Diabetes on Circulating Apoptotic Microparticles in Patients with Chronic Hepatitis C.

Zuwala-Jagiello J, Pazgan-Simon M, Murawska-Cialowicz E, Simon K.

In Vivo. 2017 Sep-Oct;31(5):1027-1034.


Supplemental Content

Loading ...
Support Center